Veeda to open Phase I unit in Malaysia
19 May 2011 | Gemma Sharman Scrip Clinical Research
First UK medtech campus: innovation-focused and a hot-house for industry Four brands but no MabThera in Indian rituximab market flux Pfenex-Agila plot cost-effective joint effort for biosimilars Strides wants Malaysian unit to transform biologic economics
FEATURES & ANALYSIS
Scrip Clinical Research Features & Analysis
Evaluation of cardiovascular risk in clinical trials Get on the technology train; how to train global nurses EndPoint - Dr Frederick Young, INC Research New approaches bring hope for peripheral artery disease
Other Features & Analysis
Eucomed: proposed overhaul of EU reg system mostly positive with one caveat How the evolving Brazilian and Russian healthcare landscape will impact medtech firms Real-world and late-phase studies in "pharmerging" markets: challenges and best practices in implementation Accessing the Indian and Chinese healthcare markets: is the opportunity worth the investment?